Seth Lederman's most recent trade in Tonix Pharmaceuticals Holding Corp was a trade of 134,504 Stock Option done . Disclosure was reported to the exchange on Feb. 24, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 134,504 | 134,504 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 134,503 | 134,503 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 21.55 per share. | 15 May 2025 | 4,000 | 4,005 (0%) | 0% | 21.6 | 86,200 | Common Stock, $0.001 par value |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 123,958 | 123,958 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 123,958 | 123,958 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Other type of transaction at price $ 3.60 per share. | 05 Feb 2025 | 5 | 5 (0%) | 0% | 3.6 | 18 | Common Stock, $0.001 par value |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 05 Feb 2025 | 1 | 0 (0%) | 0% | 0 | Common Stock, $0.001 par value | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,903,680 | 1,903,680 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,903,680 | 1,903,680 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Lederman Seth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,309,911 | 1,309,911 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 1,309,911 | 1,309,911 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Lederman Seth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 235,320 | 235,320 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 235,320 | 235,320 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 700,000 | 700,000 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 700,000 | 700,000 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 29 Jun 2022 | 20,000 | 24,235 (0%) | 0% | 1.7 | 34,200 | Common Stock, $0.001 par value |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.24 per share. | 25 Mar 2022 | 100,000 | 112,177 (0%) | 0% | 0.2 | 24,500 | Common Stock, $0.001 par value |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 5,000,000 | 5,000,000 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 5,000,000 | 5,000,000 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 5,000,000 | 5,000,000 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 5,000,000 | 5,000,000 | - | - | Stock Option | |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.61 per share. | 28 Sep 2021 | 12,000 | 12,177 (0%) | 0% | 0.6 | 7,320 | Common Stock, $0.001 par value |
| Tonix Pharma Holding Corp | Seth Lederman | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 24 Mar 2021 | 16,733 | 135,000 (0%) | 0% | 1.3 | 22,088 | Common Stock, $0.001 par value |